Back to top
more

Cardlytics, Inc. (CDLX)

(Delayed Data from NSDQ)

$88.00 USD

88.00
321,181

+1.18 (1.36%)

Updated Jan 24, 2020 04:00 PM ET

Add to portfolio

2-Buy   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.66%
17.94%
9.57%
5.30%
2.19%
10.75%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

F Value | A Growth | D Momentum | C VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for January 22nd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 22nd

CDLX AMK ADAP AAPL

Zacks Equity Research

Will Cardlytics Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Cardlytics.

CDLX

Zacks Equity Research

Here's Why Cardlytics, Inc. (CDLX) is a Great Momentum Stock to Buy

Does Cardlytics, Inc. (CDLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

CDLX

Zacks Equity Research

Cardlytics, Inc. (CDLX) Moves to Buy: Rationale Behind the Upgrade

Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CDLX

Zacks Equity Research

Cardlytics, Inc. (CDLX) Hits Fresh High: Is There Still Room to Run?

Cardlytics, Inc. (CDLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CDLX SPOT PSN NTDTY

Zacks Equity Research

Cardlytics, Inc. (CDLX) Surpasses Q3 Earnings and Revenue Estimates

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 120.00% and 13.89%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

CDLX

Zacks Equity Research

Will Cardlytics, Inc. (CDLX) Report Negative Earnings Next Week? What You Should Know

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDLX

Zacks Equity Research

Cardlytics, Inc. (CDLX) Moves to Buy: Rationale Behind the Upgrade

Cardlytics, Inc. (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CDLX

Zacks Equity Research

Cardlytics, Inc. (CDLX) Reports Q2 Loss, Tops Revenue Estimates

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 47.83% and 11.23%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

CDLX

Zacks Equity Research

Analysts Estimate Cardlytics, Inc. (CDLX) to Report a Decline in Earnings: What to Look Out for

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDLX

Zacks Equity Research

Fiserv (FISV) to Post Q2 Earnings: What's in the Offing?

Fiserv's (FISV) second-quarter 2019 results to reflect revenue growth and better operating performance.

SPGI FISV IQV CDLX

Zacks Equity Research

IQVIA (IQV) to Report Q2 Earnings: What's in the Offing?

IQVIA's (IQV) second-quarter 2019 results are likely to benefit from continued market penetration of analytics and technology-enabled offerings across the company's TAS and R&DS businesses.

CAR SPGI IQV CDLX

Zacks Equity Research

Here's Why Momentum Investors Will Love Cardlytics, Inc. (CDLX)

Does Cardlytics, Inc. (CDLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

CDLX

Zacks Equity Research

Cardlytics, Inc. (CDLX) Hits 52-Week High, Can the Run Continue?

Cardlytics, Inc. (CDLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CDLX TTEC SMGZY JT

Zacks Equity Research

All You Need to Know About Cardlytics, Inc. (CDLX) Rating Upgrade to Strong Buy

Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CDLX

Zacks Equity Research

Moving Average Crossover Alert: Cardlytics

Cardlytics, Inc. (CDLX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

CDLX

Zacks Equity Research

Cardlytics (CDLX) Catches Eye: Stock Jumps 7.4%

Cardlytics (CDLX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

BCOR CDLX

Zacks Equity Research

Zacks.com featured highlights include: ADTRAN, Cardlytics, Molina and Carlisle

Zacks.com featured highlights include: ADTRAN, Cardlytics, Molina and Carlisle

ADTN CSL MOH CDLX

Zacks Equity Research

Bet on These 4 Top Liquid Stocks for Solid Returns

Here are four impressive liquid stocks that are poised to offer marvelous returns.

ADTN CSL MOH CDLX

Tirthankar Chakraborty

New Strong Buy Stocks for May 30th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday:

NVEE NSSC MGLN CDLX CBRE

Zacks Equity Research

Cardlytics, Inc. (CDLX) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Cardlytics, Inc. (CDLX).

CDLX

Zacks Equity Research

Cardlytics, Inc. (CDLX) Upgraded to Buy: Here's Why

Cardlytics, Inc. (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CDLX

Zacks Equity Research

Cardlytics, Inc. (CDLX) Reports Q1 Loss, Misses Revenue Estimates

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 37.84% and -0.03%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CDLX

Zacks Equity Research

Analysts Estimate Cardlytics, Inc. (CDLX) to Report a Decline in Earnings: What to Look Out for

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDLX

Zacks Equity Research

Verisk (VRSK) to Post Q4 Earnings: What's in the Cards?

Organic growth, lower tax rate and contributions from acquisitions are likely to boost Verisk's (VRSK) Q4 results.

VRSK CPRT CNDT CDLX